March 21, 2023
The Silence makes the most noise.
This really should shock no one but it looks as though Medtronic Diabetes is about to undergo a reduction in force. Like Tandem Medtronic is having a tough time competing with Insulet. Like Tandem Medtronic management can’t adapt to the changing landscape of the insulin pump world. Like Tandem Medtronic foolishly believes that new products will come along and save the day.
Meanwhile back in the Boston area the Bruins are setting new records, the Celtics look to be a pretty good basketball team, the Boston Marathon is coming and Insulet continues to dominate. No rumors of layoffs, no . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.